TrialBritish journal of clinical pharmacology2018

Evaluation of a Janus kinase 1 inhibitor, PF-04965842, in healthy subjects: A phase 1, randomized, placebo-controlled, dose-escalation study.

Elena Peeva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.